Using Blinatumomab in Acute Lymphoblastic Leukemia
0 意见
• 06/15/23
0
0
嵌入
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论